APO Research
Talk to an analyst

APO RESEARCH · REPORT

Steroids APIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Steroids APIs Industry Growth and Trends Forecast to 2032

23 December 2025111 pages

Choose your research edition.

Industry ResearchSteroids APIs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroids APIs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Steroids APIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroids APIs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroids APIs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Steroids APIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Steroids APIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Steroids APIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Steroids APIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Steroids APIs include Teva, Sanofi, Merck, Pfizer, Hubei Gedian, Henan Lihua, GSK, Bayer and Symbiotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Steroids APIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Steroids APIs market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Steroids APIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Steroids APIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Steroids APIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Steroids APIs Market by Company

Teva

Sanofi

Merck

Pfizer

Hubei Gedian

Henan Lihua

GSK

Bayer

Symbiotec

Olon

Lupin

Ipca Laboratories

Cipla

Cambrex

Axplora

Aspen API

Steroids APIs Segment by Type

Corticosteroids APIs

Sex Hormone Steroids APIs

Steroids APIs Segment by Application

Veterinary Medicine

Human Pharmaceuticals

Others

Steroids APIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroids APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroids APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroids APIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Steroids APIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Steroids APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Corticosteroids APIs Table 2. Major Company of Sex Hormone Steroids APIs Table 3. Global Steroids APIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Steroids APIs Sales by Type (2021-2026) & (t) Table 5. Global Steroids APIs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Steroids APIs Sales Market Share in Value by Type (2021-2026) Table 8. Global Steroids APIs Price by Type (2021-2026) & (USD/t) Table 9. Global Steroids APIs Sales by Type (2027-2032) & (t) Table 10. Global Steroids APIs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Steroids APIs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Steroids APIs Sales Market Share in Value by Type (2027-2032) Table 13. Global Steroids APIs Price by Type (2027-2032) & (USD/t) Table 14. North America Steroids APIs Sales by Type (2021-2026) & (t) Table 15. North America Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Steroids APIs Sales by Type (2021-2026) & (t) Table 17. Europe Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Steroids APIs Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Steroids APIs Sales by Type (2021-2026) & (t) Table 21. Latin America Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Steroids APIs Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Steroids APIs Sales by Type (2021-2026) & (US$ Million) Table 24. Steroids APIs Industry Trends Table 25. Steroids APIs Industry Drivers Table 26. Steroids APIs Industry Opportunities and Challenges Table 27. Steroids APIs Industry Restraints Table 28. Global Steroids APIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Steroids APIs Revenue Market Share by Company (2021-2026) Table 30. Global Steroids APIs Sales by Company (2021-2026) & (t) Table 31. Global Steroids APIs Sales Share by Company (2021-2026) Table 32. Global Steroids APIs Market Price by Company (2021-2026) & (USD/t) Table 33. Global Steroids APIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Steroids APIs Major Company Production Sites and Headquarters Table 35. Global Steroids APIs Company, Product Type & Application Table 36. Global Steroids APIs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Steroids APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Steroids APIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Steroids APIs Sales by Region (2021-2026) & (t) Table 41. Global Steroids APIs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Steroids APIs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Steroids APIs Sales Market Share in Value by Region (2021-2026) Table 44. Global Steroids APIs Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Steroids APIs Sales by Region (2027-2032) & (t) Table 46. Global Steroids APIs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Steroids APIs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Steroids APIs Sales Market Share in Value by Region (2027-2032) Table 49. Global Steroids APIs Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Steroids APIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Steroids APIs Sales by Application (2021-2026) & (t) Table 52. Global Steroids APIs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Steroids APIs Sales Market Share in Value by Application (2021-2026) Table 55. Global Steroids APIs Price by Application (2021-2026) & (USD/t) Table 56. Global Steroids APIs Sales by Application (2027-2032) & (t) Table 57. Global Steroids APIs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Steroids APIs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Steroids APIs Sales Market Share in Value by Application (2027-2032) Table 60. Global Steroids APIs Price by Application (2027-2032) & (USD/t) Table 61. North America Steroids APIs Sales by Application (2021-2026) & (t) Table 62. North America Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Steroids APIs Sales by Application (2021-2026) & (t) Table 64. Europe Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Steroids APIs Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Steroids APIs Sales by Application (2021-2026) & (t) Table 68. Latin America Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Steroids APIs Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Steroids APIs Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Teva Steroids APIs Product Portfolio Table 75. Teva Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Sanofi Steroids APIs Product Portfolio Table 80. Sanofi Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Merck Steroids APIs Product Portfolio Table 85. Merck Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Pfizer Steroids APIs Product Portfolio Table 90. Pfizer Recent Development Table 91. Hubei Gedian Company Information Table 92. Hubei Gedian Business Overview Table 93. Hubei Gedian Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Hubei Gedian Steroids APIs Product Portfolio Table 95. Hubei Gedian Recent Development Table 96. Henan Lihua Company Information Table 97. Henan Lihua Business Overview Table 98. Henan Lihua Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Henan Lihua Steroids APIs Product Portfolio Table 100. Henan Lihua Recent Development Table 101. GSK Company Information Table 102. GSK Business Overview Table 103. GSK Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. GSK Steroids APIs Product Portfolio Table 105. GSK Recent Development Table 106. Bayer Company Information Table 107. Bayer Business Overview Table 108. Bayer Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Bayer Steroids APIs Product Portfolio Table 110. Bayer Recent Development Table 111. Symbiotec Company Information Table 112. Symbiotec Business Overview Table 113. Symbiotec Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Symbiotec Steroids APIs Product Portfolio Table 115. Symbiotec Recent Development Table 116. Olon Company Information Table 117. Olon Business Overview Table 118. Olon Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Olon Steroids APIs Product Portfolio Table 120. Olon Recent Development Table 121. Lupin Company Information Table 122. Lupin Business Overview Table 123. Lupin Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Lupin Steroids APIs Product Portfolio Table 125. Lupin Recent Development Table 126. Ipca Laboratories Company Information Table 127. Ipca Laboratories Business Overview Table 128. Ipca Laboratories Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Ipca Laboratories Steroids APIs Product Portfolio Table 130. Ipca Laboratories Recent Development Table 131. Cipla Company Information Table 132. Cipla Business Overview Table 133. Cipla Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. Cipla Steroids APIs Product Portfolio Table 135. Cipla Recent Development Table 136. Cambrex Company Information Table 137. Cambrex Business Overview Table 138. Cambrex Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Cambrex Steroids APIs Product Portfolio Table 140. Cambrex Recent Development Table 141. Axplora Company Information Table 142. Axplora Business Overview Table 143. Axplora Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Axplora Steroids APIs Product Portfolio Table 145. Axplora Recent Development Table 146. Aspen API Company Information Table 147. Aspen API Business Overview Table 148. Aspen API Steroids APIs Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. Aspen API Steroids APIs Product Portfolio Table 150. Aspen API Recent Development Table 151. North America Steroids APIs Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 152. North America Steroids APIs Sales by Country (2021-2026) & (t) Table 153. North America Steroids APIs Sales Market Share by Country (2021-2026) Table 154. North America Steroids APIs Sales Forecast by Country (2027-2032) & (t) Table 155. North America Steroids APIs Sales Market Share Forecast by Country (2027-2032) Table 156. North America Steroids APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Steroids APIs Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Steroids APIs Market Share by Country (2021-2026) Table 159. North America Steroids APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Steroids APIs Market Share Forecast by Country (2027-2032) Table 161. Europe Steroids APIs Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 162. Europe Steroids APIs Sales by Country (2021-2026) & (t) Table 163. Europe Steroids APIs Sales Market Share by Country (2021-2026) Table 164. Europe Steroids APIs Sales Forecast by Country (2027-2032) & (t) Table 165. Europe Steroids APIs Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Steroids APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Steroids APIs Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Steroids APIs Market Share by Country (2021-2026) Table 169. Europe Steroids APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Steroids APIs Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Steroids APIs Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Steroids APIs Sales by Country (2021-2026) & (t) Table 173. Asia-Pacific Steroids APIs Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Steroids APIs Sales Forecast by Country (2027-2032) & (t) Table 175. Asia-Pacific Steroids APIs Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Steroids APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Steroids APIs Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Steroids APIs Market Share by Country (2021-2026) Table 179. Asia-Pacific Steroids APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Steroids APIs Market Share Forecast by Country (2027-2032) Table 181. Latin America Steroids APIs Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 182. Latin America Steroids APIs Sales by Country (2021-2026) & (t) Table 183. Latin America Steroids APIs Sales Market Share by Country (2021-2026) Table 184. Latin America Steroids APIs Sales Forecast by Country (2027-2032) & (t) Table 185. Latin America Steroids APIs Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Steroids APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Steroids APIs Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Steroids APIs Market Share by Country (2021-2026) Table 189. Latin America Steroids APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Steroids APIs Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Steroids APIs Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Steroids APIs Sales by Country (2021-2026) & (t) Table 193. Middle East and Africa Steroids APIs Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Steroids APIs Sales Forecast by Country (2027-2032) & (t) Table 195. Middle East and Africa Steroids APIs Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Steroids APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Steroids APIs Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Steroids APIs Market Share by Country (2021-2026) Table 199. Middle East and Africa Steroids APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Steroids APIs Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Steroids APIs Distributors List Table 204. Steroids APIs Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Steroids APIs Image Figure 2. Global Steroids APIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Steroids APIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Steroids APIs Sales (2021-2032) & (t) Figure 5. Corticosteroids APIs Image Figure 6. Global Corticosteroids APIs Sales YoY Growth (2021-2032) & (t) Figure 7. Sex Hormone Steroids APIs Image Figure 8. Global Sex Hormone Steroids APIs Sales YoY Growth (2021-2032) & (t) Figure 9. Global Steroids APIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Steroids APIs Market Share by Type 2025 VS 2032 Figure 11. North America Steroids APIs Sales Market Share in Volume by Type in 2025 Figure 12. North America Steroids APIs Sales Market Share in Value by Type in 2025 Figure 13. Europe Steroids APIs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Steroids APIs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Steroids APIs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Steroids APIs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Steroids APIs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Steroids APIs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Steroids APIs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Steroids APIs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Steroids APIs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Veterinary Medicine Image Figure 24. Global Veterinary Medicine Sales YoY Growth (2021-2032) & (t) Figure 25. Human Pharmaceuticals Image Figure 26. Global Human Pharmaceuticals Sales YoY Growth (2021-2032) & (t) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (t) Figure 29. Global Steroids APIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Steroids APIs Market Share by Application 2025 VS 2032 Figure 31. North America Steroids APIs Sales Market Share in Volume by Application in 2025 Figure 32. North America Steroids APIs Sales Market Share in Value by Application in 2025 Figure 33. Europe Steroids APIs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Steroids APIs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Steroids APIs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Steroids APIs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Steroids APIs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Steroids APIs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Steroids APIs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Steroids APIs Sales Market Share in Value by Application in 2025 Figure 41. North America Steroids APIs Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 42. North America Steroids APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Steroids APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Steroids APIs Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. Europe Steroids APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Steroids APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Steroids APIs Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Asia-Pacific Steroids APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Steroids APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Steroids APIs Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Latin America Steroids APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Steroids APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Steroids APIs Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Middle East and Africa Steroids APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Steroids APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Steroids APIs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Steroids APIs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids APIs
  • Sex Hormone Steroids APIs
Applications
  • Veterinary Medicine
  • Human Pharmaceuticals
  • Others
Companies covered
  • Teva
  • Sanofi
  • Merck
  • Pfizer
  • Hubei Gedian
  • Henan Lihua
  • GSK
  • Bayer
  • Symbiotec
  • Olon
  • Lupin
  • Ipca Laboratories
  • Cipla
  • Cambrex
  • Axplora
  • Aspen API

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Steroids APIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Steroids APIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Steroids APIs Market by Type
  6. 1.3.1 Corticosteroids APIs
  7. 1.3.2 Sex Hormone Steroids APIs
  8. 1.4 Global Steroids APIs Market Size by Type
  9. 1.4.1 Global Steroids APIs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Steroids APIs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Steroids APIs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Steroids APIs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Steroids APIs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Steroids APIs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Steroids APIs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Steroids APIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Steroids APIs Industry Trends
  2. 2.2 Steroids APIs Industry Drivers
  3. 2.3 Steroids APIs Industry Opportunities and Challenges
  4. 2.4 Steroids APIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Steroids APIs Revenue (2021-2026)
  2. 3.2 Global Top Players by Steroids APIs Sales (2021-2026)
  3. 3.3 Global Top Players by Steroids APIs Price (2021-2026)
  4. 3.4 Global Steroids APIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Steroids APIs Major Company Production Sites & Headquarters
  6. 3.6 Global Steroids APIs Company, Product Type & Application
  7. 3.7 Global Steroids APIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Steroids APIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Steroids APIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Steroids APIs Tier 1, Tier 2, and Tier 3
4 Steroids APIs Regional Status and Outlook
  1. 4.1 Global Steroids APIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Steroids APIs Historic Market Size by Region
  3. 4.2.1 Global Steroids APIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Steroids APIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Steroids APIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Steroids APIs Forecasted Market Size by Region
  7. 4.3.1 Global Steroids APIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Steroids APIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Steroids APIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Steroids APIs by Application
  1. 5.1 Steroids APIs Market by Application
  2. 5.1.1 Veterinary Medicine
  3. 5.1.2 Human Pharmaceuticals
  4. 5.1.3 Others
  5. 5.2 Global Steroids APIs Market Size by Application
  6. 5.2.1 Global Steroids APIs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Steroids APIs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Steroids APIs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Steroids APIs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Steroids APIs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Steroids APIs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Steroids APIs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Steroids APIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Steroids APIs Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Steroids APIs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Steroids APIs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Steroids APIs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Hubei Gedian
  26. 6.5.1 Hubei Gedian Company Information
  27. 6.5.2 Hubei Gedian Business Overview
  28. 6.5.3 Hubei Gedian Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Gedian Steroids APIs Product Portfolio
  30. 6.5.5 Hubei Gedian Recent Developments
  31. 6.6 Henan Lihua
  32. 6.6.1 Henan Lihua Company Information
  33. 6.6.2 Henan Lihua Business Overview
  34. 6.6.3 Henan Lihua Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Henan Lihua Steroids APIs Product Portfolio
  36. 6.6.5 Henan Lihua Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Steroids APIs Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Steroids APIs Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Symbiotec
  50. 6.9.1 Symbiotec Company Information
  51. 6.9.2 Symbiotec Business Overview
  52. 6.9.3 Symbiotec Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Symbiotec Steroids APIs Product Portfolio
  54. 6.9.5 Symbiotec Recent Developments
  55. 6.10 Olon
  56. 6.10.1 Olon Company Information
  57. 6.10.2 Olon Business Overview
  58. 6.10.3 Olon Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Olon Steroids APIs Product Portfolio
  60. 6.10.5 Olon Recent Developments
  61. 6.11 Lupin
  62. 6.11.1 Lupin Company Information
  63. 6.11.2 Lupin Business Overview
  64. 6.11.3 Lupin Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lupin Steroids APIs Product Portfolio
  66. 6.11.5 Lupin Recent Developments
  67. 6.12 Ipca Laboratories
  68. 6.12.1 Ipca Laboratories Company Information
  69. 6.12.2 Ipca Laboratories Business Overview
  70. 6.12.3 Ipca Laboratories Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ipca Laboratories Steroids APIs Product Portfolio
  72. 6.12.5 Ipca Laboratories Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Steroids APIs Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Cambrex
  80. 6.14.1 Cambrex Company Information
  81. 6.14.2 Cambrex Business Overview
  82. 6.14.3 Cambrex Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cambrex Steroids APIs Product Portfolio
  84. 6.14.5 Cambrex Recent Developments
  85. 6.15 Axplora
  86. 6.15.1 Axplora Company Information
  87. 6.15.2 Axplora Business Overview
  88. 6.15.3 Axplora Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Axplora Steroids APIs Product Portfolio
  90. 6.15.5 Axplora Recent Developments
  91. 6.16 Aspen API
  92. 6.16.1 Aspen API Company Information
  93. 6.16.2 Aspen API Business Overview
  94. 6.16.3 Aspen API Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aspen API Steroids APIs Product Portfolio
  96. 6.16.5 Aspen API Recent Developments
7 North America by Country
  1. 7.1 North America Steroids APIs Sales by Country
  2. 7.1.1 North America Steroids APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Steroids APIs Sales by Country (2021-2026)
  4. 7.1.3 North America Steroids APIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Steroids APIs Market Size by Country
  6. 7.2.1 North America Steroids APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Steroids APIs Market Size by Country (2021-2026)
  8. 7.2.3 North America Steroids APIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Steroids APIs Sales by Country
  2. 8.1.1 Europe Steroids APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Steroids APIs Sales by Country (2021-2026)
  4. 8.1.3 Europe Steroids APIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Steroids APIs Market Size by Country
  6. 8.2.1 Europe Steroids APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Steroids APIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Steroids APIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Steroids APIs Sales by Country
  2. 9.1.1 Asia-Pacific Steroids APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Steroids APIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Steroids APIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Steroids APIs Market Size by Country
  6. 9.2.1 Asia-Pacific Steroids APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Steroids APIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Steroids APIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Steroids APIs Sales by Country
  2. 10.1.1 South America Steroids APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Steroids APIs Sales by Country (2021-2026)
  4. 10.1.3 South America Steroids APIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Steroids APIs Market Size by Country
  6. 10.2.1 South America Steroids APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Steroids APIs Market Size by Country (2021-2026)
  8. 10.2.3 South America Steroids APIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Steroids APIs Sales by Country
  2. 11.1.1 Middle East and Africa Steroids APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Steroids APIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Steroids APIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Steroids APIs Market Size by Country
  6. 11.2.1 Middle East and Africa Steroids APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Steroids APIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Steroids APIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Steroids APIs Value Chain Analysis
  2. 12.1.1 Steroids APIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Steroids APIs Production Mode & Process
  7. 12.2 Steroids APIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Steroids APIs Distributors
  10. 12.2.3 Steroids APIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst